Skip to content

Price / book at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
2.5×+0.2×
Natera, Inc. logo
Natera, Inc.NTRA
16×+0.6×
Agilent Technologies logo
Agilent TechnologiesA
4.6×-0.4×
Idexx Laboratories logo
Idexx LaboratoriesIDXX
28.7×+5.2×
Danaher logo
DanaherDHR
2.5×-0.4×
Guardant Health logo
Guardant HealthGH
36.8×

Other financials

Income statement

See full
Revenue$2.9B+9.2%
Gross profit$942.0M+9.2%
Operating income$399.0M+15.3%
Net income$252.0M+14.5%
EPS (diluted)$2.24+15.5%

Balance sheet

See full
Cash & equivalents$393.0M+109%
Total debt$6.4B-2.5%
Total equity$7.4B+6.3%
Total assets$16.7B+5.6%

Cash flow

See full
Operating cash flow$278.0M-11.5%
CapEx$114.0M-2.6%
Free cash flow$164.0M-16.8%

Valuation

See full
Market cap$21.89B+14.7%
Enterprise value$27.9B+9.5%
P/E21.4×+0.1×
P/S1.9×+0.1×

Profitability

See full
Gross margin33.2%+0.4pp
Operating margin14.3%+0.6pp
Net margin9.1%+0.2pp

Returns & leverage

See full
Return on equity14.3%+0.9pp
Debt / equity0.9×-0.1×
Current ratio1.2×-0.3×

Where this comes from

Calculated from Quest Diagnostics’s reported figures.

Based on the most recent quarter.

The official record: Quest Diagnostics’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Quest Diagnostics's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Quest Diagnostics's price / book?
Quest Diagnostics (DGX) reported price / book of 2.9× in Q1 2026.
How has Quest Diagnostics's price / book changed year-over-year?
Quest Diagnostics's price / book increased by 7.9% year-over-year, from 2.7× to 2.9×.
What is the long-term trend for Quest Diagnostics's price / book?
Over 4 years (2021 to 2025), Quest Diagnostics's price / book has grown at a -0.1% compound annual growth rate (CAGR), from 11.2× to 11.1×.
What does price / book mean?
How the market price compares to the company's accounting net worth.
How do you interpret price / book?
Below 1.0 can flag a market discount to book value (common for distressed or asset-heavy firms); high values reflect intangible value the balance sheet doesn't capture. Most informative for financials and asset-heavy businesses.
How does price / book compare across companies?
A core valuation gauge for banks and insurers; weak for asset-light firms where book value understates economic value.